Peroxisomal Biogenesis Factor 26 (PEX26) (Middle Region) Peptid
Kurzübersicht für Peroxisomal Biogenesis Factor 26 (PEX26) (Middle Region) Peptid (ABIN5513718)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Sequenz
- AIHTARQQQK QEHSGSEEAQ KPNLEGSVSH KFLSLPMLVR QLWDSAVSHF
-
Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- PEX26 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- PEX26 (Peroxisomal Biogenesis Factor 26 (PEX26))
-
Hintergrund
-
This gene belongs to the peroxin-26 gene family. It is probably required for protein import into peroxisomes. It anchors PEX1 and PEX6 to peroxisome membranes, possibly to form heteromeric AAA ATPase complexes required for the import of proteins into peroxisomes. Defects in this gene are the cause of peroxisome biogenesis disorder complementation group 8 (PBD-CG8). PBD refers to a group of peroxisomal disorders arising from a failure of protein import into the peroxisomal membrane or matrix. The PBD group is comprised of four disorders: Zellweger syndrome (ZWS), neonatal adrenoleukodystrophy (NALD), infantile Refsum disease (IRD), and classical rhizomelic chondrodysplasia punctata (RCDP). Alternatively spliced transcript variants have been identified for this gene.
Alias Symbols: PBD7A, PBD7B, PEX26M1T, Pex26pM1T
Protein Size: 305 -
Gen-ID
- 55670
-
NCBI Accession
- NM_001127649, NP_001121121
-
UniProt
- Q7Z412
Target
-